BACKGROUND: It has been suggested that micronutrients such as alpha-tocopherol, retinol, lutein, cryptoxanthin, lycopene, and alpha- and beta-carotene may help in the prevention of cervical cancer. Our aim was to investigate whether serum concentrations and/or dietary intake of micronutrients influence the regression or progression of low-grade cervical abnormalities. METHODS: In a prospective cohort study of 391 patients with cervical intraepithelial neoplasia (CIN) grade 1-2 lesions, we measured serum micronutrient concentrations in addition to a self-administered questionnaire about dietary intake. We evaluated the hazard ratio (HR) adjusted for CIN grade, human papillomavirus genotype, total energy intake and smoking status. RESULTS: In non-smoking regression subjects, regression was significantly associated with serum levels of zeaxanthin/lutein (HR 1.25, 0.78-2.01, p = 0.024). This benefit was abolished in current smokers. Regression was inhibited by high serum levels of alpha-tocopherol in smokers (p = 0.042). In progression subjects, a significant protective effect against progression to CIN3 was observed in individuals with a medium level of serum beta-carotene [HR 0.28, 95 % confidence interval (CI) 0.11-0.71, p = 0.007), although any protective effect from a higher level of serum beta-carotene was weaker or abolished (HR 0.52, 95 % CI 0.24-1.13, p = 0.098). Increasing beta-carotene intake did not show a protective effect (HR 2.30, 95 % CI 0.97-5.42, p = 0.058). CONCLUSIONS: Measurements of serum levels of carotenoids suggest that regression is modulated by smoking status. Maintaining a medium serum level of beta-carotene has a protective effect for progression; however, carotene intake is not correlated with serum levels of carotenoids.
BACKGROUND: It has been suggested that micronutrients such as alpha-tocopherol, retinol, lutein, cryptoxanthin, lycopene, and alpha- and beta-carotene may help in the prevention of cervical cancer. Our aim was to investigate whether serum concentrations and/or dietary intake of micronutrients influence the regression or progression of low-grade cervical abnormalities. METHODS: In a prospective cohort study of 391 patients with cervical intraepithelial neoplasia (CIN) grade 1-2 lesions, we measured serum micronutrient concentrations in addition to a self-administered questionnaire about dietary intake. We evaluated the hazard ratio (HR) adjusted for CIN grade, human papillomavirus genotype, total energy intake and smoking status. RESULTS: In non-smoking regression subjects, regression was significantly associated with serum levels of zeaxanthin/lutein (HR 1.25, 0.78-2.01, p = 0.024). This benefit was abolished in current smokers. Regression was inhibited by high serum levels of alpha-tocopherol in smokers (p = 0.042). In progression subjects, a significant protective effect against progression to CIN3 was observed in individuals with a medium level of serum beta-carotene [HR 0.28, 95 % confidence interval (CI) 0.11-0.71, p = 0.007), although any protective effect from a higher level of serum beta-carotene was weaker or abolished (HR 0.52, 95 % CI 0.24-1.13, p = 0.098). Increasing beta-carotene intake did not show a protective effect (HR 2.30, 95 % CI 0.97-5.42, p = 0.058). CONCLUSIONS: Measurements of serum levels of carotenoids suggest that regression is modulated by smoking status. Maintaining a medium serum level of beta-carotene has a protective effect for progression; however, carotene intake is not correlated with serum levels of carotenoids.
Authors: K Syrjänen; M Hakama; S Saarikoski; M Väyrynen; M Yliskoski; S Syrjänen; V Kataja; O Castrén Journal: Sex Transm Dis Date: 1990 Jan-Mar Impact factor: 2.830
Authors: Christopher G Slatore; Alyson J Littman; David H Au; Jessie A Satia; Emily White Journal: Am J Respir Crit Care Med Date: 2007-11-07 Impact factor: 21.405
Authors: Chaitali Ghosh; Julie A Baker; Kirsten B Moysich; Ruqayyah Rivera; John R Brasure; Susan E McCann Journal: Nutr Cancer Date: 2008 Impact factor: 2.900
Authors: Anna R Giuliano; Erin M Siegel; Denise J Roe; Silvandeiede Ferreira; Maria Luiza Baggio; Lenice Galan; Eliane Duarte-Franco; Luisa L Villa; Thomas E Rohan; James R Marshall; Eduardo L Franco Journal: J Infect Dis Date: 2003-11-03 Impact factor: 5.226
Authors: C Nagata; H Shimizu; H Yoshikawa; K Noda; S Nozawa; A Yajima; S Sekiya; H Sugimori; Y Hirai; K Kanazawa; M Sugase; T Kawana Journal: Br J Cancer Date: 1999-12 Impact factor: 7.640
Authors: Marius Alexandru Moga; Lorena Dima; Andreea Balan; Alexandru Blidaru; Oana Gabriela Dimienescu; Cezar Podasca; Sebastian Toma Journal: Int J Mol Sci Date: 2021-01-10 Impact factor: 5.923